Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 4/2013

01.04.2013 | Original Paper

Invasive breast cancer: a significant correlation between histological types and molecular subgroups

verfasst von: A. Caldarella, C. Buzzoni, E. Crocetti, S. Bianchi, V. Vezzosi, P. Apicella, M. Biancalani, A. Giannini, C. Urso, F. Zolfanelli, E. Paci

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The special types of breast cancer seem to have not only distinct morphological features but also distinct biological features.

Materials and methods

Women diagnosed with a first primary invasive breast cancer in the 2004–2005 period were identified through Tuscan Cancer Registry. Information on age, tumor size, lymph node status, histological type and grade, hormonal receptors, HER2 immunohistochemical expression were collected. Five subtypes were defined: luminal A, luminal B HER2+, luminal B HER2−, triple negative, and HER2 positive. The association between the histological type and molecular subgroups was assessed by a Fisher’s exact test, and a multinomial logistic regression model was used.

Results

Out of 1,487 patients, 34 % were luminal A subtype, 25 % luminal B HER2−, 11 % luminal B HER2+, 19 % triple negative, and 10.2 % HER2+; 58.5 % of cancers were ductal NOS types. With luminal A as reference, histological types distribution was significantly different between the subgroups. Mucinous, tubular, and cribriform histotypes were found among luminal A cancers more than in other subgroups; all medullary carcinomas were triple negative cancers. Pathological stage at diagnosis was more advanced, and histological grade was lower among subgroups other than luminal A.

Conclusions

Significant association between breast cancer histotypes and molecular subgroups was found.
Literatur
Zurück zum Zitat Anderson WF, Pfeiffer RM, Dores GM, Sherman ME (2006) Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers 15(10):1899–1905CrossRef Anderson WF, Pfeiffer RM, Dores GM, Sherman ME (2006) Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers 15(10):1899–1905CrossRef
Zurück zum Zitat Caldarella A, Crocetti E, Bianchi S, Vezzosi V, Urso C, Biancalani M, Zappa M (2011) Female breast cancer status according to ER, PR and HER2 expression: a population based analysis. Pathol Oncol Res 17(3):753–758PubMedCrossRef Caldarella A, Crocetti E, Bianchi S, Vezzosi V, Urso C, Biancalani M, Zappa M (2011) Female breast cancer status according to ER, PR and HER2 expression: a population based analysis. Pathol Oncol Res 17(3):753–758PubMedCrossRef
Zurück zum Zitat Colleoni M, Rotmensz N, Maisonneuve P, Mastropasqua MG, Luini A, Veronesi P, Intra M, Montagna E, Cancello G, Cardillo A, Mazza M, Perri G, Iorfida M, Pruneri G, Goldhirsch A, Viale G (2012) Outcome of special types of luminal breast cancer. Annals Oncol 23(6):1428–1436CrossRef Colleoni M, Rotmensz N, Maisonneuve P, Mastropasqua MG, Luini A, Veronesi P, Intra M, Montagna E, Cancello G, Cardillo A, Mazza M, Perri G, Iorfida M, Pruneri G, Goldhirsch A, Viale G (2012) Outcome of special types of luminal breast cancer. Annals Oncol 23(6):1428–1436CrossRef
Zurück zum Zitat Cristofanilli M, Gonzalez-Angulo A, Sneige N, Kau SW, Broglio K, Theriault RL, Valero V, Buzdar AU, Kuerer H, Buccholz TA, Hortobagyi GN (2005) Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol 23(1):41–48PubMedCrossRef Cristofanilli M, Gonzalez-Angulo A, Sneige N, Kau SW, Broglio K, Theriault RL, Valero V, Buzdar AU, Kuerer H, Buccholz TA, Hortobagyi GN (2005) Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol 23(1):41–48PubMedCrossRef
Zurück zum Zitat Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow up. Histopathology 19:403–410PubMedCrossRef Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow up. Histopathology 19:403–410PubMedCrossRef
Zurück zum Zitat Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (2000) International classification of diseases for oncology, 3rd edn. World Health Organization, Geneva Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (2000) International classification of diseases for oncology, 3rd edn. World Health Organization, Geneva
Zurück zum Zitat Goldrisch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ, Panel members (2011) Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22:1736–1747CrossRef Goldrisch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ, Panel members (2011) Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22:1736–1747CrossRef
Zurück zum Zitat Gruver AM, Portier BP, Tubbs RR (2011) Molecualr pathology of breast cancer. Arch Pathol Lab Med 135:544–557PubMed Gruver AM, Portier BP, Tubbs RR (2011) Molecualr pathology of breast cancer. Arch Pathol Lab Med 135:544–557PubMed
Zurück zum Zitat Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (2012) WHO classification of tumours, vol 4. IARC WHO Classification of Tumours, no 4 Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (2012) WHO classification of tumours, vol 4. IARC WHO Classification of Tumours, no 4
Zurück zum Zitat Li CI, Uribe DJ, Daling JR (2005) Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93:1046–1052PubMedCrossRef Li CI, Uribe DJ, Daling JR (2005) Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93:1046–1052PubMedCrossRef
Zurück zum Zitat Louwman MWJ, Vriezen M, van Beek MWPM, Tutein Nolthenius-Puylaert CBJE, van der Sangen MJC, Roumen RM, Kiemeney LALM, Coebergh JWW (2007) Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands. Int J Cancer 121:127–135PubMedCrossRef Louwman MWJ, Vriezen M, van Beek MWPM, Tutein Nolthenius-Puylaert CBJE, van der Sangen MJC, Roumen RM, Kiemeney LALM, Coebergh JWW (2007) Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands. Int J Cancer 121:127–135PubMedCrossRef
Zurück zum Zitat Metzger-Filho O, Tutt A, de Azambuja E, Saini KS, Viale G, Loi S, Bradbury I, Bliss JM, Azim HA Jr, Di Leo A, Baselga J, Sotiriou C, Piccard-Gebhart M (2012) Dissecting the heterogeneity of triple-negative breast cancer. JCO 30:1879–1887CrossRef Metzger-Filho O, Tutt A, de Azambuja E, Saini KS, Viale G, Loi S, Bradbury I, Bliss JM, Azim HA Jr, Di Leo A, Baselga J, Sotiriou C, Piccard-Gebhart M (2012) Dissecting the heterogeneity of triple-negative breast cancer. JCO 30:1879–1887CrossRef
Zurück zum Zitat Nagao T, Kinoshita T, Hojo T, Tsuda K, Fujimara Y (2012) The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics. Breast 21(3):289–295PubMedCrossRef Nagao T, Kinoshita T, Hojo T, Tsuda K, Fujimara Y (2012) The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics. Breast 21(3):289–295PubMedCrossRef
Zurück zum Zitat Rakha EA, El-Sayed ME, Powe DG, Green AR, Habashy H, Grainge MJ, Robertson JF, Blamey R, Gee J, Nicholson RI, Lee AH, Ellis IO (2008) Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. Eur J Cancer 44:73–83PubMedCrossRef Rakha EA, El-Sayed ME, Powe DG, Green AR, Habashy H, Grainge MJ, Robertson JF, Blamey R, Gee J, Nicholson RI, Lee AH, Ellis IO (2008) Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. Eur J Cancer 44:73–83PubMedCrossRef
Zurück zum Zitat Schnitt SJ (2010) Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Mod Pathol 23:S60–S64PubMedCrossRef Schnitt SJ (2010) Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Mod Pathol 23:S60–S64PubMedCrossRef
Zurück zum Zitat Simpson PT, Reis Filho JS, Lakhani SR (2010) Breast pathology: beyond morphology. Sem Diagn Pathol 27:91–96CrossRef Simpson PT, Reis Filho JS, Lakhani SR (2010) Breast pathology: beyond morphology. Sem Diagn Pathol 27:91–96CrossRef
Zurück zum Zitat Vincent-Salomon A, Gruel N, Lucchesi C, MacGrogan G, Dendale R, Sigal-Zafrani B, Longy M, Raynal V, Pierron G, de Mascarel I, Taris C, Stopp-Lyonnel D, Pierga JY, Salmon R, Sastre-Garau X, Fourquet A, Delattre O, de Cremoux P, Aurias A (2007) Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Breast Cancer Res 9(2):R24PubMedCrossRef Vincent-Salomon A, Gruel N, Lucchesi C, MacGrogan G, Dendale R, Sigal-Zafrani B, Longy M, Raynal V, Pierron G, de Mascarel I, Taris C, Stopp-Lyonnel D, Pierga JY, Salmon R, Sastre-Garau X, Fourquet A, Delattre O, de Cremoux P, Aurias A (2007) Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Breast Cancer Res 9(2):R24PubMedCrossRef
Zurück zum Zitat Vu-Nishino H, Tavassoli FA, Ahrens WA, Haffty BG (2005) Clinicopathologic features and log-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT). Int J Radiat Oncol Biol Phys 62(4):1040–1047PubMedCrossRef Vu-Nishino H, Tavassoli FA, Ahrens WA, Haffty BG (2005) Clinicopathologic features and log-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT). Int J Radiat Oncol Biol Phys 62(4):1040–1047PubMedCrossRef
Zurück zum Zitat Weigelt R, Reis-Filho JS (2009) Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol 6(12):718–730PubMedCrossRef Weigelt R, Reis-Filho JS (2009) Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol 6(12):718–730PubMedCrossRef
Zurück zum Zitat Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LFA, de Jong D, Van de Vijver MJ, Van’t Veer LJ, Peterse JL (2008) Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 216:141–150PubMedCrossRef Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LFA, de Jong D, Van de Vijver MJ, Van’t Veer LJ, Peterse JL (2008) Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 216:141–150PubMedCrossRef
Zurück zum Zitat Yerushalmi R, Hayes MM, Gelmon KA (2009) Breast carcinoma-rare types: review of the literature. Annals Oncol 20:1763–1770CrossRef Yerushalmi R, Hayes MM, Gelmon KA (2009) Breast carcinoma-rare types: review of the literature. Annals Oncol 20:1763–1770CrossRef
Metadaten
Titel
Invasive breast cancer: a significant correlation between histological types and molecular subgroups
verfasst von
A. Caldarella
C. Buzzoni
E. Crocetti
S. Bianchi
V. Vezzosi
P. Apicella
M. Biancalani
A. Giannini
C. Urso
F. Zolfanelli
E. Paci
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 4/2013
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-012-1365-1

Weitere Artikel der Ausgabe 4/2013

Journal of Cancer Research and Clinical Oncology 4/2013 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.